BR9712675A - Agonistas do receptor de eritropoietina circularmente permutados. - Google Patents
Agonistas do receptor de eritropoietina circularmente permutados.Info
- Publication number
- BR9712675A BR9712675A BR9712675-6A BR9712675A BR9712675A BR 9712675 A BR9712675 A BR 9712675A BR 9712675 A BR9712675 A BR 9712675A BR 9712675 A BR9712675 A BR 9712675A
- Authority
- BR
- Brazil
- Prior art keywords
- erythropoietin receptor
- receptor agonists
- exchanged
- proteins
- circularly exchanged
- Prior art date
Links
- 108010075944 Erythropoietin Receptors Proteins 0.000 title abstract 3
- 102100036509 Erythropoietin receptor Human genes 0.000 title abstract 3
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 229940087983 Erythropoietin receptor agonist Drugs 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3404496P | 1996-10-25 | 1996-10-25 | |
| PCT/US1997/018703 WO1998018926A1 (en) | 1996-10-25 | 1997-10-23 | Circularly permuted erythropoietin receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712675A true BR9712675A (pt) | 1999-10-19 |
Family
ID=21873960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712675-6A BR9712675A (pt) | 1996-10-25 | 1997-10-23 | Agonistas do receptor de eritropoietina circularmente permutados. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060172932A1 (enExample) |
| EP (1) | EP0939816A1 (enExample) |
| JP (1) | JP2001503266A (enExample) |
| KR (1) | KR20000052807A (enExample) |
| CN (1) | CN1234073A (enExample) |
| AU (1) | AU721196B2 (enExample) |
| BR (1) | BR9712675A (enExample) |
| CA (1) | CA2268001A1 (enExample) |
| CZ (1) | CZ130199A3 (enExample) |
| NO (1) | NO991906D0 (enExample) |
| NZ (1) | NZ334546A (enExample) |
| PL (1) | PL189756B1 (enExample) |
| WO (1) | WO1998018926A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7309687B1 (en) | 1999-04-13 | 2007-12-18 | The Kenneth S. Warren Institute, Inc. | Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin |
| US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
| US7604960B2 (en) | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
| US8236561B2 (en) | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
| US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| US7297680B2 (en) | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
| US7527961B2 (en) | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
| US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| US7192759B1 (en) | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
| US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| PA8536201A1 (es) | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
| KR100979025B1 (ko) | 2001-12-07 | 2010-08-30 | 크루셀 홀란드 비.브이. | 바이러스, 바이러스 단리물 및 백신의 생산 |
| ATE414144T1 (de) | 2003-05-09 | 2008-11-15 | Crucell Holland Bv | Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon |
| AU2005325768A1 (en) * | 2005-01-25 | 2006-08-03 | Apollo Life Sciences Limited | Molecules and chimeric molecules thereof |
| US8128933B2 (en) | 2005-11-23 | 2012-03-06 | Acceleron Pharma, Inc. | Method of promoting bone growth by an anti-activin B antibody |
| EA201692543A1 (ru) | 2005-11-23 | 2017-08-31 | Акселерон Фарма Инк. | Антагонисты активина-actriia и их применение для стимулирования роста кости |
| EP1966237A2 (en) * | 2005-11-24 | 2008-09-10 | Laboratoires Serono SA | Erythropoietin polypeptides and uses thereof |
| US8895016B2 (en) | 2006-12-18 | 2014-11-25 | Acceleron Pharma, Inc. | Antagonists of activin-actriia and uses for increasing red blood cell levels |
| CA2677007A1 (en) | 2007-02-01 | 2008-08-07 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for treating or preventing breast cancer |
| TWI782836B (zh) | 2007-02-02 | 2022-11-01 | 美商艾瑟勒朗法瑪公司 | 衍生自ActRIIB的變體與其用途 |
| CA3039330C (en) | 2007-02-09 | 2021-11-09 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| CN103877564A (zh) | 2007-09-18 | 2014-06-25 | 阿塞勒隆制药公司 | 活化素-actriia拮抗剂和减少或抑制fsh分泌的用途 |
| JP5922928B2 (ja) | 2008-08-14 | 2016-05-24 | アクセルロン ファーマ， インコーポレイテッド | 赤血球レベルを高めるためのｇｄｆトラップの使用 |
| US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
| CN102482339B (zh) | 2009-06-08 | 2015-06-17 | 阿塞勒隆制药公司 | 用于增加产热脂肪细胞的方法 |
| EP2440577A4 (en) | 2009-06-12 | 2013-01-23 | Acceleron Pharma Inc | SHORTEN ACTRIIB FC FUSION PROTEINS |
| ES2658292T3 (es) | 2009-11-17 | 2018-03-09 | Acceleron Pharma, Inc. | Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular |
| CN103298832A (zh) | 2010-11-08 | 2013-09-11 | 阿塞勒隆制药公司 | Actriia结合剂及其用途 |
| WO2013184938A2 (en) | 2012-06-08 | 2013-12-12 | Alkermes. Inc. | Fusion polypeptides comprising mucin-domain polypeptide linkers |
| MX366336B (es) | 2012-11-02 | 2019-07-05 | Celgene Corp | Antagonistas de activina - actrii y usos para el tratar trastornos oseos y otros. |
| AU2015274277B2 (en) | 2014-06-13 | 2021-03-18 | Acceleron Pharma, Inc. | Methods and compositions for treating ulcers |
| MA41052A (fr) | 2014-10-09 | 2017-08-15 | Celgene Corp | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii |
| SMT202300166T1 (it) | 2014-12-03 | 2023-07-20 | Celgene Corp | Antagonisti di attivina- actrii e usi per il trattamento di sindrome mielodisplastica |
| CN110144010B9 (zh) * | 2018-02-14 | 2021-01-05 | 上海洛启生物医药技术有限公司 | 阻断型pd-l1驼源单域抗体及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| AU8735991A (en) * | 1990-09-28 | 1992-04-28 | Ortho Pharmaceutical Corporation | Hybrid growth factors |
| US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| US5635599A (en) * | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
-
1997
- 1997-10-23 EP EP97913680A patent/EP0939816A1/en not_active Withdrawn
- 1997-10-23 WO PCT/US1997/018703 patent/WO1998018926A1/en not_active Ceased
- 1997-10-23 AU AU50810/98A patent/AU721196B2/en not_active Ceased
- 1997-10-23 CA CA002268001A patent/CA2268001A1/en not_active Abandoned
- 1997-10-23 BR BR9712675-6A patent/BR9712675A/pt not_active Application Discontinuation
- 1997-10-23 PL PL97332960A patent/PL189756B1/pl not_active IP Right Cessation
- 1997-10-23 CN CN97198973A patent/CN1234073A/zh active Pending
- 1997-10-23 CZ CZ991301A patent/CZ130199A3/cs unknown
- 1997-10-23 JP JP52052898A patent/JP2001503266A/ja not_active Abandoned
- 1997-10-23 KR KR1019990703627A patent/KR20000052807A/ko not_active Ceased
- 1997-10-23 NZ NZ334546A patent/NZ334546A/xx unknown
-
1999
- 1999-04-21 NO NO991906A patent/NO991906D0/no not_active Application Discontinuation
-
2004
- 2004-10-25 US US10/972,962 patent/US20060172932A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060172932A1 (en) | 2006-08-03 |
| EP0939816A1 (en) | 1999-09-08 |
| NZ334546A (en) | 2000-12-22 |
| PL332960A1 (en) | 1999-10-25 |
| KR20000052807A (ko) | 2000-08-25 |
| NO991906L (no) | 1999-04-21 |
| CZ130199A3 (cs) | 1999-07-14 |
| CA2268001A1 (en) | 1998-05-07 |
| AU5081098A (en) | 1998-05-22 |
| NO991906D0 (no) | 1999-04-21 |
| CN1234073A (zh) | 1999-11-03 |
| WO1998018926A1 (en) | 1998-05-07 |
| JP2001503266A (ja) | 2001-03-13 |
| PL189756B1 (pl) | 2005-09-30 |
| AU721196B2 (en) | 2000-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712675A (pt) | Agonistas do receptor de eritropoietina circularmente permutados. | |
| CY1112101T1 (el) | Νευροτροφικοι παραγοντες | |
| CA2251842A1 (en) | Small molecule mimetics of erythropoietin | |
| ES2149149T1 (es) | Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion. | |
| DK1482041T3 (da) | NL6-TIE-receptor-tyrosinkinase-ligand-homolog | |
| BR9811039A (pt) | Citocina de mamìferos: interleucina-b30 e reagentes relacionados | |
| BR9714355A (pt) | Novos agonistas de receptor flt3 | |
| BR0115124B1 (pt) | dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo. | |
| ES2145580T3 (es) | Metodos y composiciones para analizar moleculas de acido nucleico que emplean tecnicas basadas en el tamaño. | |
| BR9808646A (pt) | Sequenciador de gene e processos | |
| BR9812096A (pt) | Proteìna receptora/ligante solúvel interleucina-6 quimérica, seus análogos e seus usos | |
| BR0109060A (pt) | Método para colorir cabelos usando corantes catiÈnicos | |
| BRPI0413426A (pt) | antagonistas de receptor novo | |
| BR9713668A (pt) | Agonistas de receptores hematopoiéticos quiméricos multifuncionais | |
| AU2001238212A1 (en) | Modified fluorescent proteins | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| MX9802730A (es) | Agonistas receptores hematopoyeticos multifuncionales. | |
| MX9703364A (es) | Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso. | |
| MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
| AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
| BR9910787A (pt) | Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src | |
| SE9602822D0 (sv) | New receptor | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| BR9808514A (pt) | Proteìnas quiméricas do ligante flt3 | |
| WO1999021994A3 (en) | Human vesicle membrane protein-like proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 15/18; C07K 14/505; C07K 14/52; A61K 38/18; C12N 5/10; C12N 5/08. Ipc: C07K 14/505 (2006.01), A61K 38/00 (2006.01) Ipc: C07K 14/505 (2006.01), A61K 38/00 (2006.01) |